Last Updated On 3/17/2022 8:42:58 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
Employment |
No Relationships to Disclose |
|
|
Leadership |
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests |
Company: Eli Lilly |
Recipient: You |
Company: Doximity |
Recipient: You |
Company: Pfizer |
Recipient: You |
Company: AstraZeneca |
Recipient: You |
Company: Viatris |
Recipient: You |
Company: Johnson & Johnson |
Recipient: You |
Company: Sanofi |
Recipient: You |
Company: Abbvie |
Recipient: You |
Company: Abbott Laboratories |
Recipient: You |
|
Honoraria |
No Relationships to Disclose |
|
|
Consulting or Advisory Role |
Company: AstraZeneca Pharmaceuticals |
Recipient: You |
|
Speakers' Bureau |
Company: Genentech |
Recipient: You |
|
Research Funding |
Company: Merck |
Recipient: Your Institution |
|
Patents, Royalties, Other Intellectual Property |
No Relationships to Disclose |
|
|
Expert Testimony |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses |
No Relationships to Disclose |
|
|
Other Relationship |
No Relationships to Disclose |
|
|
(OPTIONAL) Uncompensated Relationships |
not answered |
|
|
(OPTIONAL) Open Payments Link |
not answered |
|
|